Skip to main content
SpringerLink
Log in

Psycho-Oncology in Brain Tumour Patients

  • Chapter
  • First Online:
Neurorehabilitation in Neuro-Oncology

  • 637 Accesses

Abstract

Psycho-oncology is a multidisciplinary matter that studies the psychological, social and behavioural aspects of cancer. It can be absolutely applicable to neuro-oncology because a brain cancer is a complex health condition that can have destructive physical, cognitive and psycho-social consequences. High levels of psychological distress were found among patients and caregivers, with high scores on anxiety and depression scales. It is necessary to identify and treat mood disorders in an appropriate and effective manner using, if required, an integrated approach that includes psychotherapy and pharmacotherapy, to build customized interventions according to the needs of the patient and his family.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Torta R, Mussa A. PsicOncologia. Il modello biopsicosociale. 2nd ed. Torino: Centro Scientifico Editore; 2007.

    Google Scholar 

  2. Selye H. A syndrome produced by diverse nocuous agents. J Neuropsychiatry Clin Neurosci. 1998;10(2):230–1.

    Article  CAS  PubMed  Google Scholar 

  3. Neylan TC. Hans Selye and the field of stress research. J Neuropsychiatry Clin Neurosci. 1998;10(2):230.

    Article  Google Scholar 

  4. Lazarus RS. From psychological stress to the emotions: a history of changing outlooks. Annu Rev Psychol. 1993;44:1–21.

    Article  CAS  PubMed  Google Scholar 

  5. Fredrickson BL, Joiner T. Positive emotions trigger upward spirals toward emotional Well-being. Psychol Sci. 2002;13(2):172–5.

    Article  PubMed  Google Scholar 

  6. Board F, Persky H, Hamburg DA. Psychological stress and endocrine functions. Psychosom Med. 1956;18:324–33.

    Article  CAS  PubMed  Google Scholar 

  7. Sachar EJ, Hellman L, Roffwarg HP, Halpern FS, Fukushima DK, Gallagher TF. Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Arch Gen Psychiatry. 1973;28(1):19–24.

    Article  CAS  PubMed  Google Scholar 

  8. Moreno-Villanueva M, Bürkle A. Stress hormone-mediated DNA damage response. Implications for cellular senescence and tumour progression. Curr Drug Targets. 2016;17(4):398–404.

    Article  CAS  PubMed  Google Scholar 

  9. Greer S. Healing the mind/body split: bringing the patient back into oncology. Integr Cancer Ther. 2003;2(1):5–12.

    Article  PubMed  Google Scholar 

  10. Descartes R. Meditations VI. In: Martin P, editor. The sickening mind. London: Flamingo; 1998.

    Google Scholar 

  11. Oken D. What to tell cancer patients: a study of medical attitudes. JAMA. 1961;175:1120–8.

    Article  CAS  PubMed  Google Scholar 

  12. Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196:129–36.

    Article  CAS  PubMed  Google Scholar 

  13. Engel GL, Romano J. Delirium: II. Reversibility of the electroencephalogram with experimental procedures. Arch Neurol Psychiatr. 1944;51:378–92.

    Article  Google Scholar 

  14. Engel GL. From biomedical to biopsychosocial: I. Being scientific in the human domain. Fam Syst Health. 1996;14:425–33.

    Article  Google Scholar 

  15. Kangas M, Tate RL, Williams JR, Smee RI. The effects of radiotherapy on psychosocial and cognitive functioning in adults with a primary brain tumour: a prospective evaluation. Neuro-Oncology. 2012;14(12):1485–502.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Ownsworth T, Hawkes A, Steginga S, Walker D, Shum D. A biopsychosocial perspective on adjustment and quality of life following brain tumour: a systematic evaluation of the literature. Disabil Rehabil. 2009;31(13):1038–55.

    Article  PubMed  Google Scholar 

  17. van Kessel E, Baumfalk AE, van Zandvoort MJE, Robe PA, Snijders TJ. Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumour treatment. J Neuro-Oncol. 2017;134(1):9–18.

    Article  Google Scholar 

  18. Saria MG, Courchesne N, Evangelista L, Carter J, MacManus DA, Gorman MK, et al. Cognitive dysfunction in patients with brain metastases: influences on caregiver resilience and coping. Support Care Cancer. 2017;25(4):1247–56.

    Article  PubMed  Google Scholar 

  19. Stone AA, Neale JM. New measure of daily coping: development and preliminary results. J Pers Soc Psychol. 1984;46(4):892–906.

    Article  Google Scholar 

  20. Folkman S, Lazarus RS. If it changes it must be a process: study of emotion and coping during three stages of a college examination. J Pers Soc Psychol. 1985;48(1):150–70.

    Article  CAS  PubMed  Google Scholar 

  21. Zani B, Cicognani E. Le vie del benessere. Eventi di vita e strategie di coping. 6th ed. Roma: Carocci Editore; 2008.

    Google Scholar 

  22. Grassi L, Biondi M, Costantini A. Manuale pratico di psiconcologia. Roma: Il Pensiero Scientifico Editore; 2009.

    Google Scholar 

  23. Heim E, Augustiny KF, Schaffner L, Valach L. Coping with breast cancer over time and situation. J Psychosom Res. 1993;37(5):523–42.

    Article  CAS  PubMed  Google Scholar 

  24. Heim E, Valach L, Schaffner L. Coping and psychosocial adaptation: longitudinal effects over time and stages in breast cancer. Psychosom Med. 1997;59(4):408–18.

    Article  CAS  PubMed  Google Scholar 

  25. Acquaye AA, Lin L, Vera-Bolanos E, Gilbert MR, Armstrong TS. Hope and mood changes throughout the primary brain tumour illness trajectory. Neuro-Oncology. 2016;18(1):119–25.

    Article  PubMed  Google Scholar 

  26. McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB. Depression in patients with cancer. Diagnosis, biology, and treatment. Arch Gen Psychiatry. 1995;52(2):89–99.

    Article  CAS  PubMed  Google Scholar 

  27. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.

    Article  CAS  PubMed  Google Scholar 

  28. Skarstein J, Aass N, Fossa SD, Skovlund E, Dahl AA. Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire. J Psychosom Res. 2000;49(1):27–34.

    Article  CAS  PubMed  Google Scholar 

  29. Arnold SD, Forman LM, Brigidi BD, Carter KE, Schweitzer HA, Quinn HE, et al. Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumours. Neuro-Oncology. 2008;10(2):171–81.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Anderson SI, Taylor R, Whittle IR. Mood disorders in patients after treatment for primary intracranial tumours. Br J Neurosurg. 1999;13(5):480–5.

    Article  CAS  PubMed  Google Scholar 

  31. Litofsky NS, Farace E, Anderson F Jr, Meyers CA, Huang W, Laws ER Jr. Depression in patients with high-grade glioma: results of the Glioma outcomes project. Neurosurgery. 2004;54(2):358–66.

    Article  PubMed  Google Scholar 

  32. Rooney AG, Carson A, Grant R. Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst. 2011;103(1):61–76.

    Article  PubMed  Google Scholar 

  33. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: distress management. 2nd ed. Fort Washington: NCCN; 2009.

    Google Scholar 

  34. Kroenke K, Spitzer R, Williams J. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Rooney AG, McNamara S, Mackinnon M, Fraser M, Rampling R, Carson A, et al. Screening for major depressive disorder in adults with cerebral glioma: an initial validation of 3 self-report instruments. Neuro-Oncology. 2013;15(1):122–9.

    Article  PubMed  Google Scholar 

  36. Baider L, Cooper CL, De-Nour AK. Cancer and the family. 2nd ed. New York: Wiley; 2000.

    Google Scholar 

  37. McCarter H, Furlong W, Whitton AC, Feeny D, DePauw S, Willan AR, Barr RD. Health status measurements at diagnosis as predictors of survival among adults with brain tumours. J Clin Oncol. 2006;24:3636–43.

    Article  PubMed  Google Scholar 

  38. Brown PD, Decker PA, Rummans TA, Clark MM, Frost MH, Ballman KV, Arusell RM, Buckner JC. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: comparison of patient and caregiver ratings of quality of life. Am J Clin Oncol. 2008;31(2):163–8.

    Article  PubMed  Google Scholar 

  39. Ergh TC, Hanks RA, Rapport LJ, Coleman RD. Social support moderates caregiver life satisfaction following traumatic brain injury. J Clin Exp Neuropsychol. 2003;25(8):1090–101.

    Article  PubMed  Google Scholar 

  40. Sherwood PR, Given BA, Doorenbos AZ, Given CW. Forgotten voices: lessons from bereaved caregivers of persons with a brain tumour. Int J Palliat Nurs. 2004;10:67–75.

    Article  PubMed  Google Scholar 

  41. Horowitz S, Passik SD, Malkin MG. In sickness and in health: a group intervention for spouses caring for patients with brain tumours. J Psychosoc Oncol. 1996;14:43–56.

    Article  Google Scholar 

  42. Litofsky NS, Resnick AG. The relationship between depression and brain tumours. J Neuro-Oncol. 2009;94:153–61.

    Article  Google Scholar 

  43. Northouse LL, Katapodi MC, Song L, Zhang L, Mood D. Interventions with family caregivers of cancer patients. CA Cancer J Clin. 2010;60:317–39.

    PubMed  PubMed Central  Google Scholar 

  44. Invernizzi G, Bressi C, Comazzi AM. La famiglia del malato neoplastico. Padova: Piccin; 1992.

    Google Scholar 

  45. Bloch S, Kissane D. Psychotherapies in psycho-oncology. An exciting new challenge. Br J Psychiatry. 2000;177:112–6.

    Article  CAS  PubMed  Google Scholar 

  46. Cunningham AJ. Adjuvant psychological therapy for cancer patients: putting it on the same footing as adjunctive medical therapies. Psycho-Oncology. 2000;9:367–71.

    Article  CAS  PubMed  Google Scholar 

  47. Straker N. Psychodynamic psychotherapy for cancer patients. J Psychother Pract Res. 1998;7:1–9.

    PubMed Central  Google Scholar 

  48. LeShan L. Cancers a turning point. New York: Penguin Books; 1990.

    Google Scholar 

  49. Moorey S, Greer S. Psychological therapy for patients with cancer. A new approach. Oxford: Heinemann Medical Books; 1989.

    Google Scholar 

  50. Rooney AG, Brown PD, Reijneveld JC, Grant R. Depression in glioma: a primer for clinicians and researchers. J Neurol Neurosurg Psychiatry. 2014;85(2):230–5.

    Article  PubMed  Google Scholar 

  51. Bielecka-Wajdman AM, Lesiak M, Ludyga T, Sieroń A, Obuchowicz E. Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme. Cancer Chemother Pharmacol. 2017;79(6):1249–56.

    Article  CAS  PubMed  Google Scholar 

  52. Ma J, Yang YR, Chen W, Chen MH, Wang H, Wang XD, Sun LL, Wang FZ, Wang DC. Fluoxetine synergizes with temozolomide to induce the CHOP-dependent endoplasmic reticulum stress-related apoptosis pathway in glioma cells. Oncol Rep. 2016;36(2):676–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Liu KH, Yang ST, Lin YK, Lin JW, Lee YH, Wang JY, Hu CJ, Lin EY, Chen SM, Then CK, Shen SC. Fluoxetine, an antidepressant, suppresses glioblastoma by evoking AMPAR-mediated calcium-dependent apoptosis. Oncotarget. 2015;6(7):5088–101.

    Article  PubMed  Google Scholar 

  54. Hayashi K, Michiue H, Yamada H, Takata K, Nakayama H, Wei FY, Fujimura A, Tazawa H, Asai A, Ogo N, Miyachi H, Nishiki T, Tomizawa K, Takei K, Matsui H. Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization. Sci Rep. 2016;6:1–12.

    Article  CAS  Google Scholar 

  55. Pottegård A, García Rodríguez LA, Rasmussen L, Damkier P, Friis S, Gaist D. Use of tricyclic antidepressants and risk of glioma: a nationwide case-control study. Br J Cancer. 2016;114(11):1265–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  56. Judge BS, Rentmeester LL. Antidepressant overdose-induced seizures. Neurol Clin. 2011;29:565–80.

    Article  PubMed  Google Scholar 

  57. Gross A, Devinsky O, Westbrook LE, et al. Psychotropic medication use in patients with epilepsy: effect on seizure frequency. J Neuropsychiatry Clin Neurosci. 2000;12:458–64.

    Article  CAS  PubMed  Google Scholar 

  58. Alper K, Schwartz KA, Kolts RL, Khan A. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry. 2007;62:345–54.

    Article  PubMed  Google Scholar 

  59. Ribot R, Ouyang B, Kanner AM. The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: is it worth investigating? Epilepsy Behav. 2017;70:5–9.

    Article  PubMed  Google Scholar 

  60. Torta R, Monaco F. Atypical antipsychotics and serotoninergic antidepressants in patients with epilepsy: pharmacodynamic considerations. Epilepsia. 2002;43:8–13.

    Article  PubMed  Google Scholar 

  61. Kanner AM. Depression in epilepsy: a complex reaction with unexpected consequences. Curr Opin Neurol. 2008;21:190–4.

    Article  PubMed  Google Scholar 

  62. Hesdorffer DC, Hauser WA, Olafsson E, Ludvigsson P, Kjartansson O. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol. 2006;59:35–41.

    Article  PubMed  Google Scholar 

  63. Rooney A, Grant R. SSRIs may (or may not) be a safe treatment for depression in GBM. Am J Clin Oncol. 2012;35:100.

    Article  PubMed  Google Scholar 

  64. Mendlewicz J, Lecrubier Y. Antidepressant selection: proceedings from a TCA/SSRI consensus conference. Acta Psychiatr Scand Suppl. 2000;403:5–8.

    Article  CAS  PubMed  Google Scholar 

  65. Klein M, Taphoorn MJ, Heimans JJ, van der Ploeg HM, Vandertop WP, Smit EF, Leenstra S, Tulleken CA, Boogerd W, Belderbos JS, Cleijne W, Aaronson NK. Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol. 2001;19(20):4037–47.

    Article  CAS  PubMed  Google Scholar 

  66. Caudill JS, Brown PD, Cerhan JH, Rummans TA. Selective serotonin reuptake inhibitors, glioblastoma multiforme, and impact on toxicities and overall survival: the mayo clinic experience. Am J Clin Oncol. 2011;34(4):385–7.

    Article  CAS  PubMed  Google Scholar 

  67. Valko PO, Siddique A, Linsenmeier C, Zaugg K, Held U, Hofer S. Prevalence and predictors of fatigue in glioblastoma: a prospective study. Neuro-Oncology. 2015;17(2):274–81.

    Article  CAS  PubMed  Google Scholar 

  68. Morrow GR, Hickok JT, Roscoe JA, Raubertas RF, Andrews PL, Flynn PJ, Hynes HE, Banerjee TK, Kirshner JJ, King DK. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol. 2003;21(24):4635–41.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical and Oncological Psychology, Department of Neuroscience, University of Turin, Turin, Italy

    Alice Malabaila & Riccardo Torta

Authors
  1. Alice Malabaila
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Riccardo Torta
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Rehabilitation, Neurorehabilitation Unit, Habilita S.p.A., Zingonia/Ciserano, Bergamo, Italy

    Michelangelo Bartolo

  2. University and City of Health and Science, Department Neuro-Oncology, Turin, Torino, Italy

    Riccardo Soffietti

  3. Department of Medical Psychology, VU University Medical Center Department of Medical Psychology, Amsterdam, The Netherlands

    Martin Klein

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Malabaila, A., Torta, R. (2019). Psycho-Oncology in Brain Tumour Patients. In: Bartolo, M., Soffietti, R., Klein, M. (eds) Neurorehabilitation in Neuro-Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-95684-8_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-95684-8_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-95683-1

  • Online ISBN: 978-3-319-95684-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation